Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
G
G

Givaudan

Balita

Reuters - 1 araw ang nakaraan

Citigroup cuts Givaudan to 'neutral' on limited scope for further upside

BUZZ-Citigroup cuts Givaudan to 'neutral' on limited scope for further upside ** Citigroup cuts rating on Swiss fragrance and flavour maker Givaudan GIVN.S to "neutral" from "buy", citing limited scope for further upside due to potentially easing tailwinds and tough comparisons ** Citi notes Givaudan has delivered best-in-class performance through
G
Reuters - 1 araw ang nakaraan

Top of the Street: Endesa, Givaudan, Lufthansa, Maersk

BUZZ-Top of the Street: Endesa, Givaudan, Lufthansa, Maersk A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** UBS cuts A.P. Moeller-Maersk MAERSKb.CO to "neutral" from "buy," saying the Danish shipping group's lower valuation reflects concerns about mid-term overcapacity and the logistics transformation costs ** Citigroup cuts Swiss fragrance and flavour maker Givaudan GIVN.S to "neutral" from "buy" on peak performance in 2024 that leaves little growth for
D
E
G
L
Reuters - 1 araw ang nakaraan

Ashmore, Biomerieux, Diasorin

EUROPE RESEARCH ROUNDUP-Ashmore, Biomerieux, Diasorin Oct 17 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including Ashmore, Biomerieux and Diasorin, on Thursday. HIGHLIGHTS * Ashmore ASHM.L : JP Morgan raises target price to 161p from 155p * Biomerieux BIOX.PA : HSBC raises target price to EUR 126 from EUR 120 * Diasorin DIAS.MI : HSBC cuts to hold from buy * Givaudan SA GIVN.S : Citigroup cuts target price to CHF 4650 from CHF 4750 * Oxf
A
A
A
A
B
B
C
D
E
E
G
G
I
L
L
S
T
W
Q
A
A
A
D
U
Reuters - 3 araw ang nakaraan

Bodycote, Natwest Group, TAG Immobilien

EUROPE RESEARCH ROUNDUP-Bodycote, Natwest Group, TAG Immobilien Oct 15 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bodycote, Natwest Group and TAG Immobilien, on Tuesday. HIGHLIGHTS * Bodycote Plc BOY.L : RBC raises to outperform from sector perform * Delivery Hero SE DHER.DE : Citigroup cuts to neutral from buy * Natwest Group Plc NWG.L : Jefferies raises to buy from underperform * Paragon Banking PAGPA.L : Jefferies cuts to h
A
B
B
B
C
E
G
G
J
L
L
M
R
S
Z
A
B
I
N
Reuters - 4 araw ang nakaraan

Bunzl, Equinor ASA, L'Oreal

EUROPE RESEARCH ROUNDUP-Bunzl, Equinor ASA, L'Oreal Oct 14 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Bunzl, Equinor ASA and L'Oreal, on Monday. HIGHLIGHTS * Adidas AG ADSGn.DE : UBS raises target price to EUR 279 from EUR 275 * Bunzl BNZL.L : JP Morgan raises to overweight from neutral * Equinor ASA EQNR.OL : Morgan Stanley raises to equal weight from underweight * L'Oreal OREP.PA : Citigroup cuts target price to EUR 420 from
A
A
A
B
B
B
D
D
E
G
G
H
H
I
K
L
L
O
P
S
V
V
W
A
A
B
D
G
I
Y
Reuters - 1 linggo ang nakaraan

Scent and flavour maker Givaudan tops sales forecasts on strong demand

UPDATE 2-Scent and flavour maker Givaudan tops sales forecasts on strong demand Adds analyst quotes in paragraphs 8-9, regional performance and outlook in paragraphs 10-11, shares in paragraph 12 By Jagoda Darlak and Matteo Allievi Oct 10 (Reuters) - Swiss fragrance and flavour maker Givaudan GIVN.S reported third-quarter sales above expectations on Thursday driven by sustained high demand across its markets.
G
Reuters - 1 linggo ang nakaraan

Givaudan rises after Q3 sales beat expectations

BUZZ-Givaudan rises after Q3 sales beat expectations ** Givaudan GIVN.S shares are seen up 3.2% in Julius-Baer premarket trade after the company reported Q3 sales above analysts' expectations ** Sales of Swiss fragrance and flavour maker rose 10.2% to 1.91 billion Swiss francs($2.22 billion) in Q3, ahead of analysts' average forecast of 1.86 billio
G
Reuters - 1 linggo ang nakaraan

Swiss stocks - Factors to watch on October 10

Swiss stocks - Factors to watch on October 10 ZURICH/GDANSK, Oct 10(Reuters) - Here are some of the main factors that may affect Swiss stocks on Thursday: Givaudan GIVN.S Swiss fragrance and flavour maker Givaudan reported third-quarter sales above analysts' expectations on Thursday, driven by sustained high demand across its markets. KinderCare KLC.N Partners Group PGHN.S -backed KinderCare Learning Companies notched a market valuation of about $3.1 billion after its shares opened 12.5% above i
G
U
S
Reuters - 1 linggo ang nakaraan

Fragrance and flavour maker Givaudan tops Q3 sales forecast on strong demand

CORRECTED-UPDATE 1-Fragrance and flavour maker Givaudan tops Q3 sales forecast on strong demand Corrects sales figure in paragraph 2 to "billion" from "million" Oct 10 (Reuters) - Swiss fragrance and flavour maker Givaudan GIVN.S reported third-quarter sales above analysts' expectations on Thursday, driven by sustained high demand across its markets.
G
Reuters - 1 linggo ang nakaraan

Givaudan Q3 sales beat analysts' expectations

CORRECTED-Givaudan Q3 sales beat analysts' expectations Corrects sales figure in paragraph 2 to "billion" from "million" Oct 10 (Reuters) - Swiss fragrance and flavour maker Givaudan GIVN.S reported third-quarter sales above analysts' expectations on Thursday, driven by sustained high demand across all its markets. Givaudan's sales rose 10.2% to 1.91 billion Swiss francs ($2.22 billion) on a reported basis in the July-September period, ahead of analysts' average forecast of 1.86 billion francs i
G
Reuters - 4 linggo ang nakaraan

BMW, Kingfisher, Spectris

EUROPE RESEARCH ROUNDUP-BMW, Kingfisher, Spectris Sept 18 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including BMW, Kingfisher and Spectris, on Wednesday. HIGHLIGHTS * BMW BMWG.DE : Citigroup raises to neutral from sell * Entain ENT.L : Berenberg raises target price to 1,030p from 1,020p * Kingfisher KGF.L : Citigroup raises target price to 301p from 292p * Spectris SXS.L : HSBC cuts to hold from buy * Whitbread WTB.L : Goldman Sachs cu
A
A
A
B
B
B
C
C
C
D
D
E
E
G
H
I
K
K
S
S
S
W
A
A
A
E
M
Reuters - 1 buwan ang nakaraan

Barclays weighs in on potential tariff risk for Europe if Trump wins

BUZZ-Barclays weighs in on potential tariff risk for Europe if Trump wins ** Barclays sees an up to high single-digit percent hit on European earnings if Donald Trump wins the U.S. presidential race and in the event of a full-blown trade war ** "A Trump win may raise concerns of a full-blown trade war," the British bank's strategists say in a note ** While the direct impact to potential U.S.
A
A
A
B
C
D
F
G
G
H
K
L
V
W
A
A
D
P
S
Reuters - 2 buwan ang nakaraan

Asia Morning Call-Global Markets

UPDATE 1-Asia Morning Call-Global Markets Aug 29 (Reuters) - Stock Markets closing level) Net Chng Stock Markets Net Chng S&P/ASX 200** 8071.4 0.2 NZX 50** 12470.6 19.49 DJIA 41091.42 -159.08 NIKKEI** 38371.76 83.14 Nasdaq 17556.027 -198.793 FTSE** 8343.85 -1.61 S&P 500 5592.21 -33.59 Hang Seng** 17692.45 -182.22 SPI 200 Fut 8008 -18 STI** 3391.03 -7.44 SSEC** 2837.4293 -11.3019 KOSPI** 2689.83 0.58 ---------------------------------------------------------------------------------------- Bonds Bo
A
A
G
N
S
U
J
U
U
U
Reuters - 2 buwan ang nakaraan

Asia Morning Call-Global Markets

Asia Morning Call-Global Markets Aug 29 (Reuters) - Stock Markets closing level) Net Chng Stock Markets Net Chng S&P/ASX 200** 8071.4 0.2 NZX 50** 12470.6 19.49 DJIA 40870.54 -379.96 NIKKEI** 38371.76 83.14 Nasdaq 17477.02 -277.8 FTSE** 8343.85 -1.61 S&P 500 5566.96 -58.84 Hang Seng** 17692.45 -182.22 SPI 200 Fut 7983 -43 STI** 3391.03 -7.44 SSEC** 2837.4293 -11.3019 KOSPI** 2689.83 0.58 ---------------------------------------------------------------------------------------- Bonds Bonds JP 10 YR
A
A
G
N
S
U
J
U
U
U
Reuters - 2 buwan ang nakaraan

Insurance, chemical stocks keep STOXX 600 at over one-month high

UPDATE 2-Insurance, chemical stocks keep STOXX 600 at over one-month high Ageas jumps after H1 results beat estimates Covestro rises on report ADNOC complete due diligence Chip stocks mixed ahead of Nvidia results French consumer confidence for August in line with estimates STOXX 600 up 0.3% Updated at 1610 GMT By Pranav Kashyap and Lisa Pauline Mattackal Aug 28 (Reuters) - The benchmark European stock index rose to its highest since July on Wednesday, boosted by insurance and chemical stocks ah
A
E
G
L
N
S
A
E
F
G
Reuters - 3 buwan ang nakaraan

Symrise slips, analysts points to lack of beat, guidance hike

BUZZ-Symrise slips, analysts points to lack of beat, guidance hike ** Shares in Symrise SY1G.DE slip around 2% after it posted in-line H1 results and confirmed its guidance, with analysts noting that investors were likely expecting more ** "We believe the market was looking rather for a slight beat to the consensus," Konstantin Wiechert at Baader H
G
S
G
Reuters - 3 buwan ang nakaraan

Symrise's half-year sales rise on fragrance business growth

UPDATE 2-Symrise's half-year sales rise on fragrance business growth H1 sales rise 6.3% year-on-year to 2.57 billion euros H1 EBITDA rises 11.5% to 529.8 million euros Sees 2024 organic growth at upper end of 5-7% guidance Adds CFO quote in paragraphs 5-6, share reaction in paragraph 8, analyst comments paragraph 9, division detail paragraph 11 By Antonis Pothitos Aug 1 (Reuters) - German flavour and fragrance maker Symrise SY1G.DE posted a 6.3% rise in its half-year sales on Thursday, in line w
G
K
L
S
Reuters - 3 buwan ang nakaraan

Dsm-firmenich shares jump after core earnings forecast hike

UPDATE 2-Dsm-firmenich shares jump after core earnings forecast hike Adds CEO quote from analyst call in paragraphs 6-8, share move in paragraph 2 By Dimitri Rhodes and Anna Peverieri July 30 (Reuters) - Dutch chemicals maker dsm-firmenich DSFIR.AS raised its core earnings forecast for 2024 on Tuesday, banking on savings from the restructuring of its vitamin business and continued integration of DSM and Firmenich's legacy businesses.
G
S
N
Reuters - 3 buwan ang nakaraan

Dsm-firmenich raises forecast on vitamin business

Dsm-firmenich raises forecast on vitamin business July 30 (Reuters) - Dutch chemicals maker dsm-firmenich DSFIR.AS raised its annual core earnings forecast on Tuesday, helped by the vitamin transformation programme and improving business conditions. The company now sees adjusted earnings before interest, tax, depreciation and amortisation (EBITDA) of around 2 billion euros ($2.16 billion) in 2024, up from the 1.9 billion euros previously forecast.
G
S
Reuters - 3 buwan ang nakaraan

B&M, LVMH, Ocado

EUROPE RESEARCH ROUNDUP-B&M, LVMH, Ocado July 24 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including B&M, LVMH and Ocado on Wednesday. HIGHLIGHTS * B&M BMEB.L : JP Morgan cuts target price to 469p from 471p * LVMH LVMH.PA : Jefferies cuts target price to EUR 690 from EUR 710 * Ocado OCDO.L : HSBC raises target price to 305p from 285p * SAP SE SAPG.DE : Jefferies raises target price to EUR 225 from EUR 210 * Tharisa Plc THST.L : Peel Hu
3
A
C
D
E
E
E
E
E
E
G
G
K
L
O
S
T
A
A
B
U

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.